beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Term ID

CHEBI:17950

Synonyms

(2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 4-O-beta-D-galactopyranosyl-beta-D-glucopyranoside
(Gal)1 (Glc)1 (Cer)1
a beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer(d18:1(4E))
beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer
beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
beta-D-galactosyl-(1->4)-beta-D-glucosylceramides
beta-D-galactosyl-1,4-beta-D-glucosylceramide
beta-D-galactosyl-1,4-beta-D-glucosylceramides
beta-D-Galp-(1->4)-beta-D-Glc-(1<->)-Cer
beta-lactosylceramide
D-Galactosyl-1,4-beta-D-glucosylceramide
Gal-beta1->4Glc-beta1->1'Cer
Galbeta1-4Glcbeta-Cer
LacCer
Lactosyl-N-acylsphingosine
Lactosylceramide
lactosylceramides
N-[(2S,3R,4E)-1-{[beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
N-lignoceroyl-1-sphingosyl lactoside

Definition

A diosylceramide having beta-D-galactosyl-(1->4)-beta-D-glucose as the disaccharide component.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide glycodiaosylceramide

beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide glycodiaosylceramide Show first 5 Terms
has subtype: beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(15Z)-tetracosenoyl]sphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(17Z)-hexacosenoyl]sphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-docosanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-eicosanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-hexadecanoylsphingosine ... Show All 14 Terms

beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(15Z)-tetracosenoyl]sphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-[(17Z)-hexacosenoyl]sphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-docosanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-eicosanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-hexadecanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-octadecanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-oleoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-tetracosanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-tetradecanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-tricosanoylsphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-(2-hydroxydocosanoyl)sphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-(docosanoyl)sphingosine beta-D-galactosyl-(1->4)-beta-D-glucosyl-N-(hexacosanoyl)sphingosine lactosylceramide 32:2 Show first 5 Terms
has_part: alpha-D-galactosyl-(1->4)-beta-D-galactosyl group

alpha-D-galactosyl-(1->4)-beta-D-galactosyl group Show first 5 Terms
has_role: human metabolite mouse metabolite

human metabolite mouse metabolite Show first 5 Terms
inverse has_functional_parent: 1-(3-O-sulfo-beta-D-galactosyl-(1->4)-beta-D-glucosyl)-N-acylsphingosine

1-(3-O-sulfo-beta-D-galactosyl-(1->4)-beta-D-glucosyl)-N-acylsphingosine Show first 5 Terms

Phenotype

Phenotype resulting from beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Phenotype where environments contain beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Phenotype modified by environments containing beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-acylsphingosine

Human Disease Model